Efficacy of K-Y Jelly in Prevention of Postoperative Sore Throat After Nasal Surgery
1 other identifier
interventional
140
1 country
1
Brief Summary
Postoperative sore throat (POST) is a fairly common side effect of general anesthesia which is caused by the mucosal injury and nerve compression associated with tracheal intubation or laryngeal mask airway device insertion. In this randomized study, the authors evaluate the effect of K-Y jelly-soaked nasopharyngeal packs on POST and postoperative nausea and vomiting in patients subjected to nasal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jul 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2021
CompletedFirst Posted
Study publicly available on registry
June 29, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedJune 29, 2022
June 1, 2022
1 month
December 16, 2021
June 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative sore throat
Postoperative sore throat
up to 6 hours postoperatively
Study Arms (2)
K-Y jelly soaked packs
EXPERIMENTALK-Y jelly soaked packs inserted for pretension of postoperative sore throat
Water soaked packs
ACTIVE COMPARATORWater soaked packs inserted for pretension of postoperative sore throat
Interventions
Water soaked packs for reduction of postoperative sore throat
Eligibility Criteria
You may qualify if:
- Patients submitted to nasal surgery under general anesthesia.
You may not qualify if:
- Acute of chronic nasopharyngeal conditions,
- Gastroesophageal reflux, regurgitation,
- History of postoperative sore throat,
- nasal surgery for malignant disease,
- concurrent or recent use of systemic or topical agents used for sore throat or
- Mallampati grade more than 2.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alaa Gamallead
Study Sites (1)
Al-Azhar University Hospitals
Cairo, Egypt
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Algarhy
Al-Azhar University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 16, 2021
First Posted
June 29, 2022
Study Start
July 1, 2022
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
June 29, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share